MW 437 Da, Purity >99%. Selective σ1 receptor antagonist. Shows centrally-mediated antianalgesic, antiaddictive and antidystonic effects in vivo. Blood-brain barrier permeable.
138356-21-5
> 99%
Solid
437 Da
C13H22Br2Cl2N2
45073418
Synthetic
MW 437 Da, Purity >99%. Selective σ1 receptor antagonist. Shows centrally-mediated antianalgesic, antiaddictive and antidystonic effects in vivo. Blood-brain barrier permeable.
138356-21-5
> 99%
Solid
437 Da
C13H22Br2Cl2N2
45073418
Synthetic
Soluble in water to 100 mM. Soluble in DMSO to 100 mM.
BD 1047 Dihydrobromide
Selective σ1 receptor antagonist. Shows centrally-mediated antianalgesic, antiaddictive and antidystonic effects in vivo. Blood-brain barrier permeable.
CN(C)CCN(C)CCC1=CC(=C(C=C1)Cl)Cl.Br.Br
InChI=1S/C13H20Cl2N2.2BrH/c1-16(2)8-9-17(3)7-6-11-4-5-12(14)13(15)10-11;;/h4-5,10H,6-9H2,1-3H3;2*1H
WOALTFHGLDVJHK-UHFFFAOYSA-N
N'-[2-(3,4-dichlorophenyl)ethyl]-N,N,N'-trimethylethane-1,2-diamine;dihydrobromide
Ambient - Can Ship with Ice
+4°C
Store under desiccating conditions, The product can be stored for up to 12 months
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab144560, BD 1047 dihydrobromide, sigma1 receptor antagonist
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com